Waberer's International Nyrt. (BUD:WABERERS)

G1 Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	142.6	54.67	67.07	90.12	58.58	76.11
Short-Term Investments	26.1	33.32	42.47	46.2	27.87	-
Trading Asset Securities	70.7	74.6	-	-	-	-
Cash & Short-Term Investments	239.4	162.59	109.54	136.33	86.45	76.11
Cash Growth	208.11%	48.43%	-19.65%	57.69%	13.59%	49.61%
Accounts Receivable	112.1	99.48	107.08	108.5	90.28	72.93
Other Receivables	2.3	15.18	19.35	13.53	17.77	21.91
Receivables	114.4	114.71	126.57	122.16	108.19	94.97
Inventory	3.7	3.98	4.78	4.17	3.63	2.56
Prepaid Expenses	-	12.99	10.46	11.44	4.27	-
Other Current Assets	87	20.15	17.56	5.2	1.35	1.28
Total Current Assets	444.5	314.42	268.9	279.29	203.89	174.93
Property, Plant & Equipment	251.1	247	245.43	181.78	148.29	158.25
Long-Term Investments	493.66	471.57	117.59	72.23	70.34	85.26
Goodwill	24.6	18.29	17.9	17.89	17.73	17.73
Other Intangible Assets	14.8	15.69	12.6	13.08	16.15	16.56
Long-Term Accounts Receivable	-	1.57	0.39	-	-	-
Long-Term Deferred Tax Assets	4.3	4.49	2.93	6.32	6.01	2.82
Other Long-Term Assets	45.64	51.87	37.81	44.77	53.27	43.41
Total Assets	1,279	1,125	703.56	615.38	515.68	498.96
Accounts Payable	93.9	93.76	96.09	98.18	87.61	81.73
Accrued Expenses	7.6	45.73	38.44	26.73	35.71	35.21
Short-Term Debt	4.5	4.31	7.02	6.99	29.92	31.82
Current Portion of Leases	40.5	47.94	45.87	36.05	53.89	62.02
Current Income Taxes Payable	0.6	0.91	3.6	1.67	1.17	2.06
Current Unearned Revenue	-	-	0.24	3.37	-	-
Other Current Liabilities	67.9	3.15	-	1.03	1.53	5.39
Total Current Liabilities	215	195.8	191.26	174.03	209.82	218.21
Long-Term Debt	112.1	114.64	113.83	113.81	20.76	-
Long-Term Leases	140.8	139.34	141.38	117.08	78.29	101.53
Long-Term Deferred Tax Liabilities	5.1	4.04	1.91	3.24	2.14	0.91
Other Long-Term Liabilities	604.3	491.53	103.63	94.11	135.85	121.92
Total Liabilities	1,077	945.43	552.29	502.28	446.86	442.57
Common Stock	6	6.01	6.12	6.12	6.12	6.15
Retained Earnings	146.6	134.7	124.15	100.6	6.2	-
Comprehensive Income & Other	14.9	11.26	20.74	6.15	56.18	50.03
Total Common Equity	167.5	151.97	151.01	112.87	68.49	56.18
Minority Interest	33.8	27.51	0.26	0.23	0.33	0.21
Shareholders' Equity	201.3	179.47	151.27	113.1	68.82	56.39
Total Liabilities & Equity	1,279	1,125	703.56	615.38	515.68	498.96
Total Debt	297.9	306.22	308.1	273.94	182.86	195.36
Net Cash (Debt)	-58.5	-143.63	-198.57	-137.62	-96.41	-119.25
Net Cash Per Share	-3.41	-8.36	-11.36	-7.87	-5.51	-6.79
Filing Date Shares Outstanding	16.75	17.16	17.48	17.48	17.48	17.48
Total Common Shares Outstanding	16.75	17.16	17.48	17.48	17.48	17.48
Working Capital	229.5	118.62	77.64	105.27	-5.94	-43.28
Book Value Per Share	10.00	8.85	8.64	6.46	3.92	3.21
Tangible Book Value	128.1	117.98	120.51	81.89	34.61	21.9
Tangible Book Value Per Share	7.65	6.87	6.89	4.69	1.98	1.25
Land	-	69.2	61.77	35.51	-	-
Machinery	-	60.53	61.19	53.41	39.81	34.77
Construction In Progress	-	-	-	-	0.45	0.22

Source: S&P Global Market Intelligence. Standard template. Financial Sources.